Articles of Association for Boule Diagnostics AB (publ)
§1 The corporate name of the company is Boule Diagnostics AB. The company is publicly owned.
§2 The company’s registered office is in Stockholm.
§3 The object of the company’s business shall be, directly or via subsidiaries, to conduct business with medical and biotechnique processes, to own and manage real estate and property, as well as related operations.
§4 The share capital of the company shall be not less than 4,800,000 SEK and not greater than 19,200,000 SEK.
§5 The number of shares in the company shall be not less than 19,000,000 and not greater than 76,000,000.
§6 The company’s board shall consist of not less than three and not more than seven members.
§7 The company shall have one or two auditors with at most two deputy auditors. The auditors may be appointed through a registered accounting firm.
§8 Notice of a general meeting shall be published in the Post- och Inrikes Tidningar as well as on the company’s website. At the time of the notice, an announcement informing of the notice will appear in Dagens Industri.
In order to participate in the general meeting, shareholders must respond to the company not later than the day indicated in the notice. This may not be a Sunday, a Swedish public holiday, a Saturday, Midsummer Eve, Christmas Eve, or New Year’s Eve and may not occur less than five weekdays prior to the general meeting.
§9 The company’s financial year is January 1 to December 31.
§10 The company’s shares shall be registered in a register according to the Swedish Financial Instruments Accounts Act (1998:1479), regarding accounting for financial instruments.
§11 Prior to a general meeting, the board may decide that shareholders shall be able to exercise their voting rights by post before the general meeting.
As agreed at the Extraordinary General Meeting November 1, 2022.